Laboratories of the Mount Sinai Hospital, New York.
J Exp Med. 1929 Sep 30;50(4):513-20. doi: 10.1084/jem.50.4.513.
It has been demonstrated that many multiples of minimal doses of Bacillus typhosus reacting factors can be neutralized by specific immune sera. The potency of a given serum can be conveniently titrated against increasing amounts of reacting factors. If the immune serum is diluted or if the amount of the reacting factors is too large for a given amount of serum, there is obtained neutralization but only irregularly. Normal and heterologous sera (therapeutic meningococcus and erysipelas horse sera) free of normal agglutinins or possessing normal agglutinins of a low titer (1:16) for Bacillus typhosus are not able to neutralize the reacting factors. There is obtained questionable neutralization with a serum possessing normal Bacillus typhosus agglutinins in dilution 1:64. The titer of the neutralizing antibodies increases in the course of immunization. Immune sera exercise a definite protection against the mortality induced by intravenous injection of Bacillus typhosus culture filtrates.
已证实,许多倍最小剂量的伤寒杆菌反应因子可被特异性免疫血清中和。给定血清的效价可以通过增加反应因子的量来方便地滴定。如果免疫血清被稀释,或者反应因子的量对于给定量的血清太大,则会发生中和反应,但只是不规则的。无正常凝集素的正常和异源血清(治疗性脑膜炎球菌和丹毒马血清)或凝集素正常但效价低(1:16)的血清不能中和反应因子。在稀释度为 1:64 的具有正常伤寒杆菌凝集素的血清中获得可疑的中和。中和抗体的效价在免疫过程中增加。免疫血清对静脉注射伤寒杆菌培养滤液引起的死亡率有一定的保护作用。